Daniel F. Fleischmann

1.4k total citations
54 papers, 721 citations indexed

About

Daniel F. Fleischmann is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel F. Fleischmann has authored 54 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 21 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel F. Fleischmann's work include Glioma Diagnosis and Treatment (26 papers), Medical Imaging Techniques and Applications (12 papers) and Brain Metastases and Treatment (10 papers). Daniel F. Fleischmann is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Medical Imaging Techniques and Applications (12 papers) and Brain Metastases and Treatment (10 papers). Daniel F. Fleischmann collaborates with scholars based in Germany, Italy and United States. Daniel F. Fleischmann's co-authors include Achim Goepferich, Maximilian Niyazi, Claus Belka, Marcus Unterrainer, Stefanie Corradini, Nathalie L. Albert, Sebastian Beck, Peter Bartenstein, Raphael Bodensohn and Indrawati Hadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and ACS Applied Materials & Interfaces.

In The Last Decade

Daniel F. Fleischmann

51 papers receiving 719 citations

Peers

Countries citing papers authored by Daniel F. Fleischmann

Since Specialization

Citations

This map shows the geographic impact of Daniel F. Fleischmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Fleischmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Fleischmann more than expected).

Fields of papers citing papers by Daniel F. Fleischmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Fleischmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Fleischmann. The network helps show where Daniel F. Fleischmann may publish in the future.

Co-authorship network of co-authors of Daniel F. Fleischmann

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Fleischmann. A scholar is included among the top collaborators of Daniel F. Fleischmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Fleischmann. Daniel F. Fleischmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Interprofessional approach to personalized medication management and therapy optimization in IBD care	Frontiers in Medicine	Daniel F. Fleischmann, Claudia Wolf et al.	1
2	Assessing the performance of emerging and existing continuous monitoring solutions under a single-blind controlled testing protocol	Elementa Science of the Anthropocene	Ethan Emerson, Ezra J. T. Levin et al.	0
3	FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls	Radiotherapy and Oncology	Adrien Holzgreve, Alexander Nitschmann et al.	7
4	Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy	Radiotherapy and Oncology	Daniel F. Fleischmann, Stefanie Corradini et al.	2
5	Tumor board simulation improves interdisciplinary decision-making in medical students	Journal of Cancer Research and Clinical Oncology	Chukwuka Eze, Lukas Käsmann et al.	1
6	Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	Clinical and Translational Radiation Oncology	Raphael Bodensohn, Daniel F. Fleischmann et al.	2
7	Encapsulation of Pioglitazone into Polymer–Nanoparticles for Potential Treatment of Atherosclerotic Diseases	ACS Applied Bio Materials	Melanie Walter, Daniel F. Fleischmann et al.	8
8	Current situation in radiation oncology residency—Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology	Strahlentherapie und Onkologie	Daniel F. Fleischmann, Michael Oertel et al.	4
9	Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)	Strahlentherapie und Onkologie	Phillip E. Melton, Rainer Fietkau et al.	1
10	Interprofessional Therapeutic Drug Monitoring of Carbapenems Improves ICU Care and Guideline Adherence in Acute-on-Chronic Liver Failure	Antibiotics	Stephan Schmid, Katharina Zimmermann et al.	4
11	High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With 18F-GE-180	Advances in Radiation Oncology	Daniel F. Fleischmann, Marcus Unterrainer et al.	1
12	PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study	Radiation Oncology	Matthias Mäurer, Lukas Käsmann et al.	4
13	Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy	Radiation Oncology	Valérie Albrecht, Nikko Brix et al.	7
14	General sites of nanoparticle biodistribution as a novel opportunity for nanomedicine	European Journal of Pharmaceutics and Biopharmaceutics	Daniel F. Fleischmann, Achim Goepferich	10
15	Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET	Clinical Nuclear Medicine	Franziska Vettermann, Marcus Unterrainer et al.	4
16	Quality of teaching radiation oncology in Germany—where do we stand?	Strahlentherapie und Onkologie	Michael Oertel, Matthias Mäurer et al.	22
17	Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles	Pharmaceutical Research	Daniel F. Fleischmann, Sebastian Beck et al.	14
18	Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation	PLoS ONE	Daniel F. Fleischmann, Marcus Unterrainer et al.	6
19	18F-FET PET prior to recurrent high-grade glioma re-irradiation—additional prognostic value of dynamic time-to-peak analysis and early static summation images?	Journal of Neuro-Oncology	Daniel F. Fleischmann, Marcus Unterrainer et al.	15
20	Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma	Journal of Neuro-Oncology	Oliver Schnell, Jun Thorsteinsdottir et al.	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact